Hira Irfan, Ahmed Imran Siddiqi, Umal Azmat, Waqas Shafiq, Irfan Yousaf, Muhammad Atif Naveed
{"title":"Dopamine Agonist-Induced Cerebrospinal Fluid Rhinorrhoea: A Case Report.","authors":"Hira Irfan, Ahmed Imran Siddiqi, Umal Azmat, Waqas Shafiq, Irfan Yousaf, Muhammad Atif Naveed","doi":"10.37029/jcas.v7i1.389","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Prolactinomas are the most common pituitary adenomas. Medical therapy with dopamine agonists (DAs) is the mainstay of treatment and rarely requires surgical manipulation. Patients may rarely present with cerebrospinal fluid (CSF) rhinorrhoea after starting therapy with DA in case of massive or invasive prolactinomas.</p><p><strong>Case description: </strong>We present a case of a 29-year-old lady with invasive prolactinoma who presented with CSF rhinorrhoea after a month of starting bromocriptine therapy with the development of meningitis and warranting early surgical repair.</p><p><strong>Practical implications: </strong>Patients with macroprolactinoma should be closely monitored initially after starting on DA to avoid life-threatening complications.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"7 1","pages":"e389"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/77/JCAS-7-389.PMC10166307.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer & allied specialties","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37029/jcas.v7i1.389","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Introduction: Prolactinomas are the most common pituitary adenomas. Medical therapy with dopamine agonists (DAs) is the mainstay of treatment and rarely requires surgical manipulation. Patients may rarely present with cerebrospinal fluid (CSF) rhinorrhoea after starting therapy with DA in case of massive or invasive prolactinomas.
Case description: We present a case of a 29-year-old lady with invasive prolactinoma who presented with CSF rhinorrhoea after a month of starting bromocriptine therapy with the development of meningitis and warranting early surgical repair.
Practical implications: Patients with macroprolactinoma should be closely monitored initially after starting on DA to avoid life-threatening complications.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
